June #24 : Fatal Attraction - by Walter Armstrong and Ronnilyn Pustil

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Nowhere Else to Go

Great Escapes

Gotta Light?

The Great Sex Debate

Made in Japan

Clipped Wings

The Vinyl Solution

Into the Woods

Hazel's House

Open Windows

S.O.S.-June 1997

Mailbox-June 1997

Ad Lip

A Higher Standard

Just Not Like a Prayer

Who's Sore-y Now?

Say What-June 1997

Devil to Pay

Web of Cries

On Pins and Needles

Fatal Attraction

Cocktails for Kids

To B or Not to B

Pot Doc Stalked

Obituaries

Alexander the Great(ish)

POZ Picks-June 1997

Skin Traders

Absolutely Fabregas

Barbarians at the Gates

Borders on Madness

A Second Look

Painful Truths

Before the Revolution

Riding Bareback

The Fleecing of Oprah

Barrier Blues

Mixed and Matched

To Tell the Truth

The Borders of Health

Road Trip Grub Tips

Following Your HAART

TLC for Your Largest Organ

Art and Soul

Farewells



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

June 1997

Fatal Attraction

by Walter Armstrong and Ronnilyn Pustil

Ecstasy + Norvir = lethal mix

When Norvir-taking Brit Phillip Kay died after downing two-and-a-half tabs of ecstasy (MDMA) last fall, his partner, Jim Lumb, wanted to know why. A toxicology report showed that the mount of MDMA in Kay’s bloodstream was equal to 22 hits of the contraband. Lumb’s suspicion of a Norvir/MDMA interaction was confirmed when Abbott Labs acknowledged that its protease inhibitor and recreational drugs may make a lethal mix. Norvir triples the MDMA in an ecstasy-lased system, the drug giant told Lumb in a letter. Add to this the fact that about 10 percent of Caucasians have a genetic problem metabolizing MDMA. The result? A Norvir-taker who superabsorbs ecstasy may be getting 10 times more than he bargained for. Web wizard Lumb set the internet abuzz with his cautionary tale. But Abbott’s mum, saying any official warning might be misconstrued as an illegal-narcotics endorsement. Even after faxes flew from Project Inform and other watchdogs, the company isn’t waving a red flag. “We’ll release an advisory letter to anyone who requests it,” says Abbott’s Kim Modory. “But there isn’t enough concrete evidence for us to send out an alert.”



[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been diagnosed with diabetes or pre-diabetes?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.